Registry of patients with acute pulmonary embolism
Official title: Pulmonary Embolism WArsaw REgistry
Run by Medical University of Warsaw · NCT03916302 · Data updated 2026-11-12
This study is collecting information from patients with acute pulmonary embolism to see how different treatments affect their recovery and to help improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 1 site (Warsaw) |
| Status | Recruiting |
| Started | January 1, 2008 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | October 27, 2023 |
| Trial ID | NCT03916302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals with objectively confirmed acute pulmonary embolism who can provide informed consent.
✕Probably not a fit
Patients who do not provide consent for participation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Pulmonary Embolism WArsaw REgistry (PE-aWARE) is an ongoing prospective observational study that collects extensive data on patients with confirmed acute pulmonary embolism (APE) at a single center. Since its initiation in January 2008, the registry aims to gather information on patient characteristics, management strategies, and outcomes to reduce mortality and complications associated with APE. Key endpoints include the occurrence of PE recurrences, bleeding complications, and mortality, which will help in developing predictive scores for better clinical management.
Why it matters
Potential benefit: If successful, this registry could significantly improve the management and outcomes of patients with acute pulmonary embolism.
How similar studies have gone: Other observational studies on pulmonary embolism have shown success in improving patient outcomes through data collection and analysis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * objectively confirmed pulmonary embolism * Informed consent for the participation in the study, according to the requirements of the ethics committee Exclusion Criteria: * lack of consent
Where it's running
-
Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw
Warsaw, Poland Recruiting
Study contacts
- Study coordinator: Piotr Pruszczyk, Prof.
- Email: piotr.pruszczyk@wum.edu.pl
- Phone: 00 48 22 502 11 44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Bedside saline-contrast electrical impedance tomography for diagnosing acute pulmonary embolism
This study will test whether a bedside saline-contrast electrical impedance tomography (EIT) scan can diagnose acute pulmonary embolism in adults with suspected PE and respiratory failure.
-
Real-world use of the EkoSonic Endovascular System for acute pulmonary embolism in Chinese patients
This study tests whether the EkoSonic Endovascular System is safe and effective for Chinese patients with acute pulmonary embolism in routine clinical care.
-
Healthy living strategies to help recover from pulmonary embolism
This study tests if two healthy living strategies can help people recover better after being hospitalized for a pulmonary embolism.
-
Registry of patients with acute cardiovascular disease in a cardiac intensive care unit
This study is looking at patients with serious heart conditions in the Cardiac Intensive Care Unit to see how they do during and after their hospital stay.
-
Using 129Xe MRI to study lung and blood conditions
This study is testing how a special MRI using 129Xe gas can help us understand lung and blood conditions better by looking at healthy people and those with specific lung diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.